Catalent announced that it has completed the installation and commissioning of four new high throughput ‘high-bay’ CGMP manufacturing suites at its facility in Kansas City, Missouri, to increase its capacity and capabilities for producing oral solid dose forms.
The project includes the installation of a new Gerteis roller compactor alongside stationary bin blenders, a capsule weight sorter, and a Syntegon high-throughput encapsulator that is capable of producing up to 156,000 capsules per hour, in either powder or minitablet dose forms. Additionally, a new automated capsule vision inspection system has been installed and commissioned to ensure product quality, with the capability to validate 100% of all capsules and tablets manufactured. The flexible design of the suites incorporates separate material and personnel entry and exit points, along with enclosed systems for material transfer to and from the processing equipment.
Catalent’s Kansas City facility provides a range of integrated services for oral solid dosage forms, from formulation development and analytical testing to clinical and commercial-scale manufacture. The site also offers comprehensive clinical packaging services, including clinical supply management, package engineering, clinical manufacturing, primary and secondary packaging, global distribution and logistics, and return/destruction services.